0001104659-23-119592.txt : 20231117
0001104659-23-119592.hdr.sgml : 20231117
20231117170035
ACCESSION NUMBER: 0001104659-23-119592
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231117
DATE AS OF CHANGE: 20231117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hudson Frederick M.
CENTRAL INDEX KEY: 0001438462
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 231419734
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm2331055-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-15
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001438462
Hudson Frederick M.
C/O SUPERNUS PHARMACEUTICALS, INC.,
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
2023-11-15
4
M
0
7457
9.24
A
42324
D
Common Stock
2023-11-15
4
S
0
3882
28.50
D
38442
D
Common Stock
2023-11-15
4
S
0
5211
28.50
D
33231
D
Director Stock Option (Right to Buy)
9.24
2023-11-15
4
M
0
7457
0
D
2015-01-21
2024-01-21
Common Stock
7457
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.49 to $28.53, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
/s/ Timothy C. Dec, as attorney-in-fact
2023-11-17